Working… Menu

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01939054
Recruitment Status : Unknown
Verified June 2015 by Binghe Xu, Chinese Academy of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : September 11, 2013
Last Update Posted : June 4, 2015
Biotech Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Binghe Xu, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2015
Estimated Study Completion Date : September 2016